Key Considerations in Outsourced “On-Site” Audits as Part of Supplier Qualification
This article reviews experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.
A pharmaceutical manufacturer can perform its own audits as part of supplier qualification; or authorize a suitable third-party audit provider to perform the audit on its behalf; or buy an audit report from a commercial provider. The main focus of interest is the final audit report, which in any case, should be written informatively and distinctly, and should enable the reader to gain a comprehensive impression of the audited firm. This article reports some experiences with the outcome of in-house audits, audits by third parties, and purchased audit reports.
Download BioPharm International's
2017 Outsourcing Resources eBook.
Articles in this issue
Customer Relationship Management in Contract Manufacturing
Preparing an Approach to Cold Chain for Cell- and Tissue-Based Therapies
Getting Biopharmaceutical Tech Transfer Right the First Time
CMOs Tackle New Challenges
Gearing Up for Biosimilars
Insourcing vs Outsourcing: Choosing the Right Strategy
Operations and Quality Oversight of CMOs
Quality Metrics and CMO Agreement
Key Considerations in Outsourced “On-Site” Audits as Part of Supplier Qualification
Recent Videos
Related Content
